Funding for this research was provided by:
Research fund of Central Denmark Region
Aarhus Universitetshospital (DK), “Spydspidspuljen”
Danish Osteoporosis Foundation
Aarhus Universitetshospital (DK), Department of Endocrinology and Internal Medicine
Text and Data Mining valid from 2018-09-17
Received: 22 May 2018
Accepted: 10 September 2018
First Online: 17 September 2018
Compliance with Ethical Standards
: Bente L. Langdahl has received honoraria for consulting and lecturing for Amgen, Merck, UCB, and TEVA and received research grants from Amgen and Novo Nordisk. Randi M. H. Tei, Cecilia H. Ramlau-Hansen, Oleguer Plana-Ripoll, Ole Brink have no conflicts of interests.
: The study complies with the principles outlined in the Declaration of Helsinki. The study was approved by the Danish Data Protection Agency.
: All informants were informed that they could withdraw their participation at any time before or during the interview without any consequences for their further fracture treatment and follow-up. The study was approved by the Danish Data Protection Agency (J. No. 2007-58-0016). We submitted the protocol to review by the Central Denmark Region Committees on Health Research Ethics, but they found that the study procedures were in accordance to the Danish osteoporosis guidelines and non-interventional. Therefore, the study did not need formal ethical approval and did not need informant consent. Nevertheless, in agreement with good clinical practice we collected informed written consent from all participants.